Robeco Institutional Asset Management
AMAG

Robeco Institutional Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Robeco Institutional Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,884
Closed -$183K – 1012
2019
Q3 		$183K Sell
15,884
-1,213,821
-99% -$12.8M ﹤0.01% 900
2019
Q2 		$12.3M Sell
1,229,705
-74,934
-6% -$808K 0.04% 423
2019
Q1 		$16.8M Buy
1,304,639
+79,007
+6% +$1.18M 0.06% 375
2018
Q4 		$18.7M Buy
1,225,632
+230,313
+23% +$4.39M 0.08% 301
2018
Q3 		$19.9M Buy
995,319
+19,571
+2% +$446K 0.08% 294
2018
Q2 		$19M Buy
975,748
+195,217
+25% +$4.32M 0.09% 279
2018
Q1 		$15.7M Buy
780,531
+2,043
+0.3% +$34.6K 0.07% 311
2017
Q4 		$10.3M Buy
778,488
+126,780
+19% +$1.91M 0.05% 366
2017
Q3 		$12M Buy
651,708
+125,719
+24% +$2.34M 0.07% 272
2017
Q2 		$9.68M Buy
525,989
+334,811
+175% +$6.63M 0.06% 311
2017
Q1 		$4.31M Buy
+191,178
New +$4.58M 0.03% 446
2015
Q4 		– Sell
-35,955
Closed -$1.43M – 822
2015
Q3 		$1.43M Hold
35,955
– – 0.01% 511
2015
Q2 		$2.48M Buy
35,955
+16,490
+85% +$1.04M 0.02% 462
2015
Q1 		$1.06M Buy
+19,465
New +$928K 0.01% 552

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Robeco Institutional Asset Management's AMAG Position: Q4 2019 in Review

Robeco Institutional Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 15,884 shares — an estimated $183K sold.

Robeco Institutional Asset Management first reported a position in AMAG in Q1 2015 and held it in 14 quarters. The position peaked at $19.9M in Q3 2018. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Robeco Institutional Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 15,884 AMAG Pharmaceuticals shares in Q4 2019, an estimated $183K.
  • Robeco Institutional Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • Robeco Institutional Asset Management's AMAG Pharmaceuticals position peaked at $19.9M in Q3 2018.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.